nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—migraine—Prednisone—psoriatic arthritis	0.761	1	CpDpCtD
Almotriptan—CYP2C19—Prednisone—psoriatic arthritis	0.0231	0.142	CbGbCtD
Almotriptan—CYP2E1—Dexamethasone—psoriatic arthritis	0.0231	0.141	CbGbCtD
Almotriptan—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0185	0.113	CbGbCtD
Almotriptan—CYP2C8—Dexamethasone—psoriatic arthritis	0.0172	0.105	CbGbCtD
Almotriptan—CYP2C19—Dexamethasone—psoriatic arthritis	0.0144	0.0884	CbGbCtD
Almotriptan—CYP3A4—Triamcinolone—psoriatic arthritis	0.014	0.0857	CbGbCtD
Almotriptan—CYP3A4—Betamethasone—psoriatic arthritis	0.012	0.0735	CbGbCtD
Almotriptan—CYP3A4—Prednisolone—psoriatic arthritis	0.0118	0.0725	CbGbCtD
Almotriptan—CYP3A4—Prednisone—psoriatic arthritis	0.0112	0.0685	CbGbCtD
Almotriptan—CYP2D6—Dexamethasone—psoriatic arthritis	0.011	0.0672	CbGbCtD
Almotriptan—CYP3A4—Dexamethasone—psoriatic arthritis	0.00699	0.0428	CbGbCtD
Almotriptan—Erythema—Betamethasone—psoriatic arthritis	0.000195	0.0026	CcSEcCtD
Almotriptan—Malaise—Triamcinolone—psoriatic arthritis	0.000194	0.00258	CcSEcCtD
Almotriptan—Malaise—Methylprednisolone—psoriatic arthritis	0.000194	0.00258	CcSEcCtD
Almotriptan—Vertigo—Triamcinolone—psoriatic arthritis	0.000193	0.00257	CcSEcCtD
Almotriptan—Syncope—Triamcinolone—psoriatic arthritis	0.000193	0.00257	CcSEcCtD
Almotriptan—Vertigo—Methylprednisolone—psoriatic arthritis	0.000193	0.00257	CcSEcCtD
Almotriptan—Syncope—Methylprednisolone—psoriatic arthritis	0.000193	0.00256	CcSEcCtD
Almotriptan—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000191	0.00254	CcSEcCtD
Almotriptan—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000189	0.00252	CcSEcCtD
Almotriptan—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000189	0.00251	CcSEcCtD
Almotriptan—Shock—Prednisolone—psoriatic arthritis	0.000188	0.0025	CcSEcCtD
Almotriptan—Convulsion—Triamcinolone—psoriatic arthritis	0.000186	0.00248	CcSEcCtD
Almotriptan—Tachycardia—Prednisolone—psoriatic arthritis	0.000186	0.00248	CcSEcCtD
Almotriptan—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.000186	0.00248	CcSEcCtD
Almotriptan—Convulsion—Methylprednisolone—psoriatic arthritis	0.000186	0.00248	CcSEcCtD
Almotriptan—Hypertension—Triamcinolone—psoriatic arthritis	0.000186	0.00247	CcSEcCtD
Almotriptan—Hypertension—Methylprednisolone—psoriatic arthritis	0.000185	0.00247	CcSEcCtD
Almotriptan—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000185	0.00246	CcSEcCtD
Almotriptan—Myalgia—Triamcinolone—psoriatic arthritis	0.000183	0.00244	CcSEcCtD
Almotriptan—Myalgia—Methylprednisolone—psoriatic arthritis	0.000183	0.00243	CcSEcCtD
Almotriptan—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000183	0.00243	CcSEcCtD
Almotriptan—Eye disorder—Prednisone—psoriatic arthritis	0.000183	0.00243	CcSEcCtD
Almotriptan—Anxiety—Methylprednisolone—psoriatic arthritis	0.000182	0.00242	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000182	0.00242	CcSEcCtD
Almotriptan—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000181	0.00241	CcSEcCtD
Almotriptan—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000181	0.00241	CcSEcCtD
Almotriptan—Discomfort—Triamcinolone—psoriatic arthritis	0.000181	0.00241	CcSEcCtD
Almotriptan—Discomfort—Methylprednisolone—psoriatic arthritis	0.000181	0.0024	CcSEcCtD
Almotriptan—Dry mouth—Triamcinolone—psoriatic arthritis	0.000179	0.00238	CcSEcCtD
Almotriptan—Angioedema—Dexamethasone—psoriatic arthritis	0.000178	0.00237	CcSEcCtD
Almotriptan—Angioedema—Betamethasone—psoriatic arthritis	0.000178	0.00237	CcSEcCtD
Almotriptan—Conjunctivitis—Methotrexate—psoriatic arthritis	0.000177	0.00235	CcSEcCtD
Almotriptan—Confusional state—Methylprednisolone—psoriatic arthritis	0.000177	0.00235	CcSEcCtD
Almotriptan—Immune system disorder—Prednisone—psoriatic arthritis	0.000176	0.00235	CcSEcCtD
Almotriptan—Malaise—Dexamethasone—psoriatic arthritis	0.000176	0.00234	CcSEcCtD
Almotriptan—Malaise—Betamethasone—psoriatic arthritis	0.000176	0.00234	CcSEcCtD
Almotriptan—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000176	0.00234	CcSEcCtD
Almotriptan—Vertigo—Dexamethasone—psoriatic arthritis	0.000175	0.00233	CcSEcCtD
Almotriptan—Vertigo—Betamethasone—psoriatic arthritis	0.000175	0.00233	CcSEcCtD
Almotriptan—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000175	0.00233	CcSEcCtD
Almotriptan—Syncope—Betamethasone—psoriatic arthritis	0.000175	0.00233	CcSEcCtD
Almotriptan—Syncope—Dexamethasone—psoriatic arthritis	0.000175	0.00233	CcSEcCtD
Almotriptan—Shock—Triamcinolone—psoriatic arthritis	0.000173	0.0023	CcSEcCtD
Almotriptan—Insomnia—Prednisolone—psoriatic arthritis	0.000173	0.0023	CcSEcCtD
Almotriptan—Shock—Methylprednisolone—psoriatic arthritis	0.000172	0.00229	CcSEcCtD
Almotriptan—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000172	0.00229	CcSEcCtD
Almotriptan—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000172	0.00228	CcSEcCtD
Almotriptan—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000172	0.00228	CcSEcCtD
Almotriptan—Epistaxis—Methotrexate—psoriatic arthritis	0.000172	0.00228	CcSEcCtD
Almotriptan—Paraesthesia—Prednisolone—psoriatic arthritis	0.000172	0.00228	CcSEcCtD
Almotriptan—Tachycardia—Triamcinolone—psoriatic arthritis	0.000171	0.00228	CcSEcCtD
Almotriptan—Mental disorder—Prednisone—psoriatic arthritis	0.000171	0.00228	CcSEcCtD
Almotriptan—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000171	0.00228	CcSEcCtD
Almotriptan—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00017	0.00226	CcSEcCtD
Almotriptan—Erythema—Prednisone—psoriatic arthritis	0.00017	0.00226	CcSEcCtD
Almotriptan—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00017	0.00226	CcSEcCtD
Almotriptan—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000169	0.00225	CcSEcCtD
Almotriptan—Convulsion—Betamethasone—psoriatic arthritis	0.000169	0.00225	CcSEcCtD
Almotriptan—Convulsion—Dexamethasone—psoriatic arthritis	0.000169	0.00225	CcSEcCtD
Almotriptan—Hypertension—Dexamethasone—psoriatic arthritis	0.000169	0.00224	CcSEcCtD
Almotriptan—Hypertension—Betamethasone—psoriatic arthritis	0.000169	0.00224	CcSEcCtD
Almotriptan—Myalgia—Betamethasone—psoriatic arthritis	0.000166	0.00221	CcSEcCtD
Almotriptan—Myalgia—Dexamethasone—psoriatic arthritis	0.000166	0.00221	CcSEcCtD
Almotriptan—Anxiety—Betamethasone—psoriatic arthritis	0.000166	0.0022	CcSEcCtD
Almotriptan—Anxiety—Dexamethasone—psoriatic arthritis	0.000166	0.0022	CcSEcCtD
Almotriptan—Discomfort—Betamethasone—psoriatic arthritis	0.000164	0.00219	CcSEcCtD
Almotriptan—Discomfort—Dexamethasone—psoriatic arthritis	0.000164	0.00219	CcSEcCtD
Almotriptan—Pain—Prednisolone—psoriatic arthritis	0.000163	0.00217	CcSEcCtD
Almotriptan—Pharyngitis—Methotrexate—psoriatic arthritis	0.000162	0.00216	CcSEcCtD
Almotriptan—Vision blurred—Prednisone—psoriatic arthritis	0.00016	0.00213	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00016	0.00213	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00016	0.00212	CcSEcCtD
Almotriptan—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000159	0.00212	CcSEcCtD
Almotriptan—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000159	0.00212	CcSEcCtD
Almotriptan—Insomnia—Triamcinolone—psoriatic arthritis	0.000159	0.00211	CcSEcCtD
Almotriptan—Insomnia—Methylprednisolone—psoriatic arthritis	0.000159	0.00211	CcSEcCtD
Almotriptan—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000158	0.0021	CcSEcCtD
Almotriptan—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000158	0.0021	CcSEcCtD
Almotriptan—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000157	0.00209	CcSEcCtD
Almotriptan—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000157	0.00209	CcSEcCtD
Almotriptan—Visual impairment—Methotrexate—psoriatic arthritis	0.000157	0.00209	CcSEcCtD
Almotriptan—Shock—Betamethasone—psoriatic arthritis	0.000157	0.00209	CcSEcCtD
Almotriptan—Shock—Dexamethasone—psoriatic arthritis	0.000157	0.00209	CcSEcCtD
Almotriptan—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000157	0.00208	CcSEcCtD
Almotriptan—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000156	0.00208	CcSEcCtD
Almotriptan—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000156	0.00208	CcSEcCtD
Almotriptan—Agitation—Prednisone—psoriatic arthritis	0.000156	0.00208	CcSEcCtD
Almotriptan—Tachycardia—Betamethasone—psoriatic arthritis	0.000156	0.00207	CcSEcCtD
Almotriptan—Tachycardia—Dexamethasone—psoriatic arthritis	0.000156	0.00207	CcSEcCtD
Almotriptan—Angioedema—Prednisone—psoriatic arthritis	0.000155	0.00207	CcSEcCtD
Almotriptan—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000155	0.00206	CcSEcCtD
Almotriptan—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000154	0.00205	CcSEcCtD
Almotriptan—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000154	0.00205	CcSEcCtD
Almotriptan—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000154	0.00205	CcSEcCtD
Almotriptan—Malaise—Prednisone—psoriatic arthritis	0.000153	0.00204	CcSEcCtD
Almotriptan—Vertigo—Prednisone—psoriatic arthritis	0.000153	0.00203	CcSEcCtD
Almotriptan—Eye disorder—Methotrexate—psoriatic arthritis	0.000153	0.00203	CcSEcCtD
Almotriptan—Syncope—Prednisone—psoriatic arthritis	0.000153	0.00203	CcSEcCtD
Almotriptan—Tinnitus—Methotrexate—psoriatic arthritis	0.000152	0.00203	CcSEcCtD
Almotriptan—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000152	0.00202	CcSEcCtD
Almotriptan—Fatigue—Triamcinolone—psoriatic arthritis	0.000151	0.00201	CcSEcCtD
Almotriptan—Fatigue—Methylprednisolone—psoriatic arthritis	0.000151	0.00201	CcSEcCtD
Almotriptan—Pain—Triamcinolone—psoriatic arthritis	0.00015	0.002	CcSEcCtD
Almotriptan—Loss of consciousness—Prednisone—psoriatic arthritis	0.000149	0.00199	CcSEcCtD
Almotriptan—Immune system disorder—Methotrexate—psoriatic arthritis	0.000147	0.00196	CcSEcCtD
Almotriptan—Convulsion—Prednisone—psoriatic arthritis	0.000147	0.00196	CcSEcCtD
Almotriptan—Hypertension—Prednisone—psoriatic arthritis	0.000147	0.00195	CcSEcCtD
Almotriptan—Chills—Methotrexate—psoriatic arthritis	0.000147	0.00195	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000145	0.00193	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000145	0.00193	CcSEcCtD
Almotriptan—Myalgia—Prednisone—psoriatic arthritis	0.000145	0.00193	CcSEcCtD
Almotriptan—Arthralgia—Prednisone—psoriatic arthritis	0.000145	0.00193	CcSEcCtD
Almotriptan—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000145	0.00193	CcSEcCtD
Almotriptan—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000144	0.00192	CcSEcCtD
Almotriptan—Anxiety—Prednisone—psoriatic arthritis	0.000144	0.00192	CcSEcCtD
Almotriptan—Insomnia—Betamethasone—psoriatic arthritis	0.000144	0.00192	CcSEcCtD
Almotriptan—Insomnia—Dexamethasone—psoriatic arthritis	0.000144	0.00192	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000144	0.00191	CcSEcCtD
Almotriptan—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000143	0.00191	CcSEcCtD
Almotriptan—Paraesthesia—Betamethasone—psoriatic arthritis	0.000143	0.0019	CcSEcCtD
Almotriptan—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000143	0.0019	CcSEcCtD
Almotriptan—Discomfort—Prednisone—psoriatic arthritis	0.000143	0.0019	CcSEcCtD
Almotriptan—Mental disorder—Methotrexate—psoriatic arthritis	0.000143	0.0019	CcSEcCtD
Almotriptan—Erythema—Methotrexate—psoriatic arthritis	0.000142	0.00189	CcSEcCtD
Almotriptan—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000141	0.00187	CcSEcCtD
Almotriptan—Dyspepsia—Betamethasone—psoriatic arthritis	0.00014	0.00187	CcSEcCtD
Almotriptan—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00014	0.00187	CcSEcCtD
Almotriptan—Dysgeusia—Methotrexate—psoriatic arthritis	0.000139	0.00185	CcSEcCtD
Almotriptan—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000139	0.00185	CcSEcCtD
Almotriptan—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000139	0.00185	CcSEcCtD
Almotriptan—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000139	0.00184	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000138	0.00183	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000138	0.00183	CcSEcCtD
Almotriptan—Back pain—Methotrexate—psoriatic arthritis	0.000137	0.00183	CcSEcCtD
Almotriptan—Fatigue—Dexamethasone—psoriatic arthritis	0.000137	0.00183	CcSEcCtD
Almotriptan—Fatigue—Betamethasone—psoriatic arthritis	0.000137	0.00183	CcSEcCtD
Almotriptan—Shock—Prednisone—psoriatic arthritis	0.000137	0.00182	CcSEcCtD
Almotriptan—Pain—Dexamethasone—psoriatic arthritis	0.000136	0.00181	CcSEcCtD
Almotriptan—Pain—Betamethasone—psoriatic arthritis	0.000136	0.00181	CcSEcCtD
Almotriptan—Nervous system disorder—Prednisone—psoriatic arthritis	0.000136	0.00181	CcSEcCtD
Almotriptan—Tachycardia—Prednisone—psoriatic arthritis	0.000135	0.0018	CcSEcCtD
Almotriptan—Skin disorder—Prednisone—psoriatic arthritis	0.000135	0.00179	CcSEcCtD
Almotriptan—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000134	0.00179	CcSEcCtD
Almotriptan—Vision blurred—Methotrexate—psoriatic arthritis	0.000134	0.00178	CcSEcCtD
Almotriptan—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000132	0.00175	CcSEcCtD
Almotriptan—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000131	0.00175	CcSEcCtD
Almotriptan—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000131	0.00175	CcSEcCtD
Almotriptan—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00013	0.00173	CcSEcCtD
Almotriptan—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00013	0.00173	CcSEcCtD
Almotriptan—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000129	0.00172	CcSEcCtD
Almotriptan—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000129	0.00172	CcSEcCtD
Almotriptan—Malaise—Methotrexate—psoriatic arthritis	0.000128	0.00171	CcSEcCtD
Almotriptan—Vertigo—Methotrexate—psoriatic arthritis	0.000128	0.0017	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000126	0.00168	CcSEcCtD
Almotriptan—Dizziness—Prednisolone—psoriatic arthritis	0.000126	0.00168	CcSEcCtD
Almotriptan—Asthenia—Triamcinolone—psoriatic arthritis	0.000126	0.00168	CcSEcCtD
Almotriptan—Abdominal pain—Betamethasone—psoriatic arthritis	0.000126	0.00168	CcSEcCtD
Almotriptan—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000126	0.00168	CcSEcCtD
Almotriptan—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000126	0.00168	CcSEcCtD
Almotriptan—Body temperature increased—Betamethasone—psoriatic arthritis	0.000126	0.00168	CcSEcCtD
Almotriptan—Asthenia—Methylprednisolone—psoriatic arthritis	0.000126	0.00167	CcSEcCtD
Almotriptan—Insomnia—Prednisone—psoriatic arthritis	0.000126	0.00167	CcSEcCtD
Almotriptan—Paraesthesia—Prednisone—psoriatic arthritis	0.000125	0.00166	CcSEcCtD
Almotriptan—Pruritus—Triamcinolone—psoriatic arthritis	0.000124	0.00165	CcSEcCtD
Almotriptan—Pruritus—Methylprednisolone—psoriatic arthritis	0.000124	0.00165	CcSEcCtD
Almotriptan—Convulsion—Methotrexate—psoriatic arthritis	0.000123	0.00164	CcSEcCtD
Almotriptan—Dyspepsia—Prednisone—psoriatic arthritis	0.000122	0.00163	CcSEcCtD
Almotriptan—Arthralgia—Methotrexate—psoriatic arthritis	0.000121	0.00161	CcSEcCtD
Almotriptan—Chest pain—Methotrexate—psoriatic arthritis	0.000121	0.00161	CcSEcCtD
Almotriptan—Myalgia—Methotrexate—psoriatic arthritis	0.000121	0.00161	CcSEcCtD
Almotriptan—Rash—Prednisolone—psoriatic arthritis	0.00012	0.0016	CcSEcCtD
Almotriptan—Dermatitis—Prednisolone—psoriatic arthritis	0.00012	0.0016	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00012	0.0016	CcSEcCtD
Almotriptan—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00012	0.0016	CcSEcCtD
Almotriptan—Fatigue—Prednisone—psoriatic arthritis	0.00012	0.00159	CcSEcCtD
Almotriptan—Headache—Prednisolone—psoriatic arthritis	0.00012	0.00159	CcSEcCtD
Almotriptan—Discomfort—Methotrexate—psoriatic arthritis	0.00012	0.00159	CcSEcCtD
Almotriptan—Confusional state—Methotrexate—psoriatic arthritis	0.000117	0.00156	CcSEcCtD
Almotriptan—Dizziness—Triamcinolone—psoriatic arthritis	0.000116	0.00155	CcSEcCtD
Almotriptan—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000116	0.00154	CcSEcCtD
Almotriptan—Dizziness—Methylprednisolone—psoriatic arthritis	0.000116	0.00154	CcSEcCtD
Almotriptan—Feeling abnormal—Prednisone—psoriatic arthritis	0.000114	0.00152	CcSEcCtD
Almotriptan—Asthenia—Betamethasone—psoriatic arthritis	0.000114	0.00152	CcSEcCtD
Almotriptan—Asthenia—Dexamethasone—psoriatic arthritis	0.000114	0.00152	CcSEcCtD
Almotriptan—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000114	0.00151	CcSEcCtD
Almotriptan—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000114	0.00151	CcSEcCtD
Almotriptan—Nausea—Prednisolone—psoriatic arthritis	0.000113	0.00151	CcSEcCtD
Almotriptan—Pruritus—Betamethasone—psoriatic arthritis	0.000113	0.0015	CcSEcCtD
Almotriptan—Pruritus—Dexamethasone—psoriatic arthritis	0.000113	0.0015	CcSEcCtD
Almotriptan—Skin disorder—Methotrexate—psoriatic arthritis	0.000113	0.0015	CcSEcCtD
Almotriptan—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000112	0.00149	CcSEcCtD
Almotriptan—Vomiting—Triamcinolone—psoriatic arthritis	0.000112	0.00149	CcSEcCtD
Almotriptan—Vomiting—Methylprednisolone—psoriatic arthritis	0.000111	0.00148	CcSEcCtD
Almotriptan—Rash—Triamcinolone—psoriatic arthritis	0.000111	0.00147	CcSEcCtD
Almotriptan—Dermatitis—Triamcinolone—psoriatic arthritis	0.000111	0.00147	CcSEcCtD
Almotriptan—Rash—Methylprednisolone—psoriatic arthritis	0.000111	0.00147	CcSEcCtD
Almotriptan—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00011	0.00147	CcSEcCtD
Almotriptan—Headache—Triamcinolone—psoriatic arthritis	0.00011	0.00146	CcSEcCtD
Almotriptan—Headache—Methylprednisolone—psoriatic arthritis	0.00011	0.00146	CcSEcCtD
Almotriptan—Body temperature increased—Prednisone—psoriatic arthritis	0.00011	0.00146	CcSEcCtD
Almotriptan—Abdominal pain—Prednisone—psoriatic arthritis	0.00011	0.00146	CcSEcCtD
Almotriptan—Diarrhoea—Betamethasone—psoriatic arthritis	0.000109	0.00145	CcSEcCtD
Almotriptan—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000109	0.00145	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000106	0.00141	CcSEcCtD
Almotriptan—Dizziness—Betamethasone—psoriatic arthritis	0.000105	0.0014	CcSEcCtD
Almotriptan—Dizziness—Dexamethasone—psoriatic arthritis	0.000105	0.0014	CcSEcCtD
Almotriptan—Insomnia—Methotrexate—psoriatic arthritis	0.000105	0.0014	CcSEcCtD
Almotriptan—Nausea—Triamcinolone—psoriatic arthritis	0.000104	0.00139	CcSEcCtD
Almotriptan—Paraesthesia—Methotrexate—psoriatic arthritis	0.000104	0.00139	CcSEcCtD
Almotriptan—Nausea—Methylprednisolone—psoriatic arthritis	0.000104	0.00138	CcSEcCtD
Almotriptan—Dyspnoea—Methotrexate—psoriatic arthritis	0.000103	0.00138	CcSEcCtD
Almotriptan—Somnolence—Methotrexate—psoriatic arthritis	0.000103	0.00137	CcSEcCtD
Almotriptan—Hypersensitivity—Prednisone—psoriatic arthritis	0.000102	0.00136	CcSEcCtD
Almotriptan—Dyspepsia—Methotrexate—psoriatic arthritis	0.000102	0.00136	CcSEcCtD
Almotriptan—Vomiting—Dexamethasone—psoriatic arthritis	0.000101	0.00135	CcSEcCtD
Almotriptan—Vomiting—Betamethasone—psoriatic arthritis	0.000101	0.00135	CcSEcCtD
Almotriptan—Rash—Dexamethasone—psoriatic arthritis	0.0001	0.00134	CcSEcCtD
Almotriptan—Rash—Betamethasone—psoriatic arthritis	0.0001	0.00134	CcSEcCtD
Almotriptan—Dermatitis—Betamethasone—psoriatic arthritis	0.0001	0.00134	CcSEcCtD
Almotriptan—Dermatitis—Dexamethasone—psoriatic arthritis	0.0001	0.00134	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.0001	0.00133	CcSEcCtD
Almotriptan—Fatigue—Methotrexate—psoriatic arthritis	0.0001	0.00133	CcSEcCtD
Almotriptan—Headache—Betamethasone—psoriatic arthritis	9.99e-05	0.00133	CcSEcCtD
Almotriptan—Headache—Dexamethasone—psoriatic arthritis	9.99e-05	0.00133	CcSEcCtD
Almotriptan—Asthenia—Prednisone—psoriatic arthritis	9.96e-05	0.00132	CcSEcCtD
Almotriptan—Pain—Methotrexate—psoriatic arthritis	9.92e-05	0.00132	CcSEcCtD
Almotriptan—Pruritus—Prednisone—psoriatic arthritis	9.82e-05	0.00131	CcSEcCtD
Almotriptan—Feeling abnormal—Methotrexate—psoriatic arthritis	9.56e-05	0.00127	CcSEcCtD
Almotriptan—Diarrhoea—Prednisone—psoriatic arthritis	9.5e-05	0.00126	CcSEcCtD
Almotriptan—Gastrointestinal pain—Methotrexate—psoriatic arthritis	9.49e-05	0.00126	CcSEcCtD
Almotriptan—Nausea—Dexamethasone—psoriatic arthritis	9.47e-05	0.00126	CcSEcCtD
Almotriptan—Nausea—Betamethasone—psoriatic arthritis	9.47e-05	0.00126	CcSEcCtD
Almotriptan—Dizziness—Prednisone—psoriatic arthritis	9.18e-05	0.00122	CcSEcCtD
Almotriptan—Body temperature increased—Methotrexate—psoriatic arthritis	9.17e-05	0.00122	CcSEcCtD
Almotriptan—Abdominal pain—Methotrexate—psoriatic arthritis	9.17e-05	0.00122	CcSEcCtD
Almotriptan—Vomiting—Prednisone—psoriatic arthritis	8.83e-05	0.00117	CcSEcCtD
Almotriptan—Rash—Prednisone—psoriatic arthritis	8.75e-05	0.00116	CcSEcCtD
Almotriptan—Dermatitis—Prednisone—psoriatic arthritis	8.74e-05	0.00116	CcSEcCtD
Almotriptan—Headache—Prednisone—psoriatic arthritis	8.7e-05	0.00116	CcSEcCtD
Almotriptan—Hypersensitivity—Methotrexate—psoriatic arthritis	8.55e-05	0.00114	CcSEcCtD
Almotriptan—Asthenia—Methotrexate—psoriatic arthritis	8.32e-05	0.00111	CcSEcCtD
Almotriptan—Nausea—Prednisone—psoriatic arthritis	8.24e-05	0.0011	CcSEcCtD
Almotriptan—Pruritus—Methotrexate—psoriatic arthritis	8.21e-05	0.00109	CcSEcCtD
Almotriptan—Diarrhoea—Methotrexate—psoriatic arthritis	7.94e-05	0.00106	CcSEcCtD
Almotriptan—Dizziness—Methotrexate—psoriatic arthritis	7.67e-05	0.00102	CcSEcCtD
Almotriptan—Vomiting—Methotrexate—psoriatic arthritis	7.38e-05	0.000981	CcSEcCtD
Almotriptan—Rash—Methotrexate—psoriatic arthritis	7.31e-05	0.000973	CcSEcCtD
Almotriptan—Dermatitis—Methotrexate—psoriatic arthritis	7.31e-05	0.000972	CcSEcCtD
Almotriptan—Headache—Methotrexate—psoriatic arthritis	7.27e-05	0.000967	CcSEcCtD
Almotriptan—Nausea—Methotrexate—psoriatic arthritis	6.89e-05	0.000917	CcSEcCtD
